1. Introduction
1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:
4. Europe Infectious Disease Diagnostics Market Landscape
4.1 Market Overview
4.2 Porter's Five Forces Analysis
- 4.2.1 Bargaining Power of Suppliers
- 4.2.2 Bargaining Power of Buyers
- 4.2.3 Threat of New Entrants
- 4.2.4 Competitive Rivalry
- 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
- 4.3.1 Raw Material Suppliers
- 4.3.2 Manufacturers
- 4.3.3 Distributors/Suppliers
- 4.3.4 End Users
5. Europe Infectious Disease Diagnostics Market – Key Market Dynamics
5.1 Growth Drivers
- 5.1.1 Prevalence of infectious diseases
- 5.1.2 Need for early and accurate diagnosis
5.2 Market Opportunities
- 5.2.1 Government initiatives for disease control
- 5.2.2 Expansion in remote testing services
5.3 Future Trends
- 5.3.1 Point-of-care testing
- 5.3.2 Molecular diagnostics advancements
5.4 Impact of Drivers and Restraints
6. Europe Infectious Disease Diagnostics Market Regional Analysis
6.1 Europe Infectious Disease Diagnostics Market Overview
6.2 Europe Infectious Disease Diagnostics Market Revenue 2020-2030 (US$ Million)
6.3 Europe Infectious Disease Diagnostics Market Forecast Analysis
7. Europe Infectious Disease Diagnostics Market Analysis – by Product
7.1 Kits & Reagents
- 7.1.1 Overview
- 7.1.2 Kits & Reagents: Europe Infectious Disease Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Instruments
- 7.2.1 Overview
- 7.2.2 Instruments: Europe Infectious Disease Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Software & Services
- 7.3.1 Overview
- 7.3.2 Software & Services: Europe Infectious Disease Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)
8. Europe Infectious Disease Diagnostics Market Analysis – by Technology
8.1 Biosensor-Based
- 8.1.1 Overview
- 8.1.2 Biosensor-Based: Europe Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8.2 Immunodiagnostics
- 8.2.1 Overview
- 8.2.2 Immunodiagnostics: Europe Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8.3 Molecular-Based Diagnostic Techniques
- 8.3.1 Overview
- 8.3.2 Molecular-Based Diagnostic Techniques: Europe Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Clinical Biology
- 8.4.1 Overview
- 8.4.2 Clinical Biology: Europe Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
9. Europe Infectious Disease Diagnostics Market Analysis – by Application Type
9.1 Laboratory Testing and Point-of-Care Testing
- 9.1.1 Overview
- 9.1.2 Clinical Biology: Europe Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10. Europe Infectious Disease Diagnostics Market – Europe Analysis
10.1 Europe
- 10.1.1 Europe Infectious Disease Diagnostics Market Breakdown, by Key
Country, 2023 and 2030 (%)
- 10.1.1.1 Europe Infectious Disease Diagnostics Market – Revenue and
Forecast Analysis – by Country
- 10.1.1.1 UK:
Europe Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
- 10.1.1.1.1 UK: Europe Infectious Disease Diagnostics Market Breakdown, by Product
- 10.1.1.1.2 UK: Europe Infectious Disease Diagnostics Market Breakdown, by Technology
- 10.1.1.1.3 UK: Europe Infectious Disease Diagnostics Market Breakdown, by Application Type
- 10.1.1.2 Germany:
Europe Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
- 10.1.1.2.1 Germany: Europe Infectious Disease Diagnostics Market Breakdown, by Product
- 10.1.1.2.2 Germany: Europe Infectious Disease Diagnostics Market Breakdown, by Technology
- 10.1.1.2.3 Germany: Europe Infectious Disease Diagnostics Market Breakdown, by Application Type
- 10.1.1.3 France:
Europe Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
- 10.1.1.3.1 France: Europe Infectious Disease Diagnostics Market Breakdown, by Product
- 10.1.1.3.2 France: Europe Infectious Disease Diagnostics Market Breakdown, by Technology
- 10.1.1.3.3 France: Europe Infectious Disease Diagnostics Market Breakdown, by Application Type
- 10.1.1.4 Russia:
Europe Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
- 10.1.1.4.1 Russia: Europe Infectious Disease Diagnostics Market Breakdown, by Product
- 10.1.1.4.2 Russia: Europe Infectious Disease Diagnostics Market Breakdown, by Technology
- 10.1.1.4.3 Russia: Europe Infectious Disease Diagnostics Market Breakdown, by Application Type
- 10.1.1.5 Italy:
Europe Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
- 10.1.1.5.1 Italy: Europe Infectious Disease Diagnostics Market Breakdown, by Product
- 10.1.1.5.2 Italy: Europe Infectious Disease Diagnostics Market Breakdown, by Technology
- 10.1.1.5.3 Italy: Europe Infectious Disease Diagnostics Market Breakdown, by Application Type
- 10.1.1.6 Rest of Europe:
Europe Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
- 10.1.1.6.1 Rest of Europe: Europe Infectious Disease Diagnostics Market Breakdown, by Product
- 10.1.1.6.2 Rest of Europe: Europe Infectious Disease Diagnostics Market Breakdown, by Technology
- 10.1.1.6.3 Rest of Europe: Europe Infectious Disease Diagnostics Market Breakdown, by Application Type
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. Europe Infectious Disease Diagnostics Market Industry Landscape
12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments
13. Company Profiles
13.1 Abbott Laboratories
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 ACON Laboratories Inc
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Bio-Rad Laboratories Inc
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 Bruker Corp
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 Cardinal Health Inc
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 Danaher Corp
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 DiaSorin SpA
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 F. Hoffmann-La Roche Ltd
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 Trinity Biotech Plc
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
14. Appendix
14.1 About Business Market Insights